Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
Journal Information
Full Title: Dis Markers
Abbreviation: Dis Markers
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
Evidence found in paper:
"supplementary 11 r codes used in this research."
COI Disclosure
Evidence found in paper:
"Conflicts of Interest The authors declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
Funding Disclosure
Evidence found in paper:
"This study was supported by the Funds of the Outstanding Young Medical Talent Training Funding Project of First Affiliated Hospital of Harbin Medical University (HYD2020JQ0020)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025